Not surprisingly, spleen, lung and liver showed lower weights and less immature cell infiltration in recipients transplanted with Tespa1-/- AML cells in comparation with controls (Supplementary Fig. S11E, F). The gene discussed is TESPA1; the disease is acute myeloid leukemia.